Comparison of computed tomography findings with clinical risks factors for endoscopic therapy in upper gastrointestinal bleeding cases.
acute upper gastrointestinal hemorrhage
computed tomography
risk assessment
Journal
Journal of clinical biochemistry and nutrition
ISSN: 0912-0009
Titre abrégé: J Clin Biochem Nutr
Pays: Japan
ID NLM: 8700907
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
27
12
2018
accepted:
16
02
2019
entrez:
9
10
2019
pubmed:
9
10
2019
medline:
9
10
2019
Statut:
ppublish
Résumé
Several risk scoring systems exist for acute upper gastrointestinal bleeding (UGIB). The clinical Rockall score (clinical RS) and the Glasgow-Blatchford score (GBS) are major risk scores that consider only clinical data. Computed tomography (CT) findings are equivocal in non-variceal UGIB. We compared CT findings with clinical data to predict mortality, rebleeding and need for endoscopic therapy in non-variceal UGIB patients. This retrospective, single-center study included 386 patients admitted to our emergency department with diagnosis of non-variceal UGIB by urgent endoscopy between January 2009 and March 2015. Multivariable logistic regression analysis was used to investigate CT findings and risk factors derived from clinical data. CT findings could not significantly predict mortality and rebleeding in non-variceal UGIB patients. However, upper gastrointestinal hemorrhage in CT findings better predicted the need for endoscopic therapy than clinical data. The adjusted odds ratios were 10.10 (95% CI 5.01-20.40) for clinical RS and 10.70 (95% CI 5.08-22.70) for the GBS. UGI hemorrhage in CT findings could predict the need for endoscopic therapy in non-variceal UGIB patients in our emergency department. CT findings as well as risk score systems may be useful for predicting the need for endoscopic therapy.
Identifiants
pubmed: 31592208
doi: 10.3164/jcbn.18-115
pii: DN/JST.JSTAGE/jcbn/18-115
pmc: PMC6769404
doi:
Types de publication
Journal Article
Langues
eng
Pagination
138-145Informations de copyright
Copyright © 2019 JCBNCopyright © 2019 JCBN.
Déclaration de conflit d'intérêts
No potential conflicts of interest were disclosed.
Références
Gastrointest Endosc. 2006 Apr;63(4):606-12
pubmed: 16564860
Aliment Pharmacol Ther. 2011 Aug;34(4):470-5
pubmed: 21707681
Gut. 1999 Mar;44(3):331-5
pubmed: 10026316
Gastrointest Endosc. 2013 Apr;77(4):551-7
pubmed: 23357496
Am J Emerg Med. 2012 Jun;30(5):673-9
pubmed: 21641145
J Gastroenterol. 2015 Dec;50(12):1162-72
pubmed: 25812518
Ann Emerg Med. 2004 Apr;43(4):525-32
pubmed: 15039700
Abdom Imaging. 2003 Sep-Oct;28(5):634-6
pubmed: 14628865
Gastrointest Endosc. 2010 Jun;71(7):1134-40
pubmed: 20598244
Am J Emerg Med. 2012 Jan;30(1):129-34
pubmed: 21185674
Acad Emerg Med. 2015 Jan;22(1):22-30
pubmed: 25556538
J Emerg Med. 2013 Jun;44(6):1083-7
pubmed: 23360648
Lancet. 2000 Oct 14;356(9238):1318-21
pubmed: 11073021
Scand J Trauma Resusc Emerg Med. 2015 Dec 30;23:109
pubmed: 26714636
Int J Clin Pract. 2010 Jun;64(7):868-74
pubmed: 20337750
Am J Emerg Med. 2013 Jan;31(1):94-9
pubmed: 23000328
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Gastrointest Endosc. 2013 Oct;78(4):576-83
pubmed: 23790755
Turk J Gastroenterol. 2012;23(5):448-55
pubmed: 23161321
Gastrointest Endosc. 2004 Jul;60(1):85-93
pubmed: 15229431
World J Gastroenterol. 2006 Dec 28;12(48):7779-85
pubmed: 17203520
Lancet. 2009 Jan 3;373(9657):5-7
pubmed: 19091391
Eur J Gastroenterol Hepatol. 2003 Apr;15(4):381-7
pubmed: 12655258
J Gastroenterol Hepatol. 2007 Sep;22(9):1404-8
pubmed: 17716345
Dig Dis Sci. 2005 Nov;50(11):2063-70
pubmed: 16240216